Nova Immunotherapeutics Limited
1 clinical trials · Sponsor
◉ Watch Nova Immunotherapeutics Limited
| Record | Firm | Date |
|---|---|---|
| The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) (NCT02500680) | Nova Immunotherapeutics Limited | 2015-07-01 |
Track Nova Immunotherapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.